Autres langues Teyi Pharmaceutical Group Co.,Ltd

Actions

002728

CNE100001WK6

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
9,910 ^CNY	+1,95%		+1,95%	-8,66%

20/08	Teyi Pharmaceutical Group Co.,Ltd publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
11/06	Teyi Pharmaceutical Group Co.,Ltd annonce la mise en œuvre de son plan de distribution de dividende final (actions A) pour 2025, payable le 18 juin 2026	CI

Autres langues

20/08	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
11/06	Teyi Pharmaceutical Group Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on 18 June 2026
27/04	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
23/03	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
23/03	Teyi Pharmaceutical Group Co.,Ltd announces Annual dividend, payable on June 18, 2026
23/10/25	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
21/08/25	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
16/07/25	Teyi Pharmaceutical Group's board elects chairman
11/06/25	Tranche Update on Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback Plan announced on June 12, 2024.
10/06/25	Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback announced on June 12, 2024, has closed with 13,729,618 shares, representing 2.69% for CNY 101.19 million.
29/05/25	Teyi Pharmaceutical Group Co.,Ltd Approves Cash Dividend for the Year 2024
28/04/25	Teyi Pharmaceutical Group Co.,Ltd Proposes Final Cash Dividend for 2024
25/04/25	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
25/04/25	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
01/04/25	Tranche Update on Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback Plan announced on June 12, 2024.
28/02/25	Teyi Pharmaceutical's Doxycycline Hydrochloride Tablets Pass Regulatory Evaluation
03/01/25	Tranche Update on Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback Plan announced on June 12, 2024.
25/10/24	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024
08/10/24	Tranche Update on Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback Plan announced on June 12, 2024.
18/07/24	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2024
02/07/24	Tranche Update on Teyi Pharmaceutical Group Co.,Ltd's Equity Buyback Plan announced on June 12, 2024.
12/06/24	Teyi Pharmaceutical to Buy Back Up to 120 Million Yuan Shares; Shares Up 3%
11/06/24	Teyi Pharmaceutical Group Co.,Ltd announces an Equity Buyback for CNY 120 million worth of its shares.
11/06/24	Teyi Pharmaceutical Group Co.,Ltd authorizes a Buyback Plan.
19/04/24	Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024